0001209191-21-028322.txt : 20210426
0001209191-21-028322.hdr.sgml : 20210426
20210426171514
ACCESSION NUMBER: 0001209191-21-028322
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210426
FILED AS OF DATE: 20210426
DATE AS OF CHANGE: 20210426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LACOB JOSEPH
CENTRAL INDEX KEY: 0001215490
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40337
FILM NUMBER: 21854942
MAIL ADDRESS:
STREET 1: 2820 ORCHARD PARKWAY
CITY: SAN JOSE
STATE: CA
ZIP: 95131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuroPace Inc
CENTRAL INDEX KEY: 0001528287
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 223550230
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 455 N. BERNARDO AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 6502372700
MAIL ADDRESS:
STREET 1: 455 N. BERNARDO AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-26
0
0001528287
NeuroPace Inc
NPCE
0001215490
LACOB JOSEPH
C/O NEUROPACE, INC.
455 N. BERNARDO AVENUE
MOUNTAIN VIEW
CA
95131
1
0
0
0
Common Stock
2021-04-26
4
A
0
334027
0.00
A
351920
I
See Footnote
Series A' Preferred Stock
0.00
2021-04-26
4
C
0
8594
0.00
D
Common Stock
8594
0
I
See Footnote
Series A' Preferred Stock
0.00
2021-04-26
4
C
0
17189
0.00
D
Common Stock
17189
0
I
See Footnote
Series B; Preferred Stock
0.00
2021-04-26
4
C
0
102747
0.00
D
Common Stock
102747
0
I
See Footnote
Series B' Preferred Stock
0.00
2021-04-26
4
C
0
205497
0.00
D
Common Stock
20549
0
I
See Footnote
Includes 111,341 shares held by Lacob Ventures LLC and 222,686 shares held by LCT18 Investments, LLC.
Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.
Shares are held by Lacob Ventures LLC.
Shares are held by LCT18 Investments.
/s/ Mark B. Weeks, Attorney-in-Fact
2021-04-26